Telemus Capital’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,400	Closed	-$295K	–	349
2021 Q2	$295K	Sell	13,400 -10,300	-43%	-$227K	0.02%	289
2021 Q1	$666K	Buy	23,700 +15,700	+196%	+$441K	0.05%	246
2020 Q4	$322K	Buy	+8,000	New	+$322K	0.02%	306